English
简体中文
Total: £ 56.28
Published Date: 2025-12-23 | Pages: 83 | Tables: 79 | Pharma & Healthcare
The global market for Parenteral Excipients was valued at US$ 1588 million in the year 2024 and is projected to reach a revised size of US$ 2283 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Parenteral excipients are excipients used in parenteral drug delivery systems. Parenteral drug delivery systems typically include intravenous injection, intramuscular injection, subcutaneous injection, and other routes of administration for directly delivering drugs into the bloodstream or tissues to achieve therapeutic effects. Parenteral excipients play multiple critical roles in parenteral drug delivery systems, such as increasing drug solubility, stability, bioavailability, and safety. Common parenteral excipients include glucose, sodium chloride, and glycerol. The selection and use of these excipients need to be determined based on the characteristics of the drugs and the route of administration to ensure the effectiveness and safety of the drugs.
North American market for Parenteral Excipients is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Parenteral Excipients is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Parenteral Excipients include Merck, Ashland, Roquette, Croda Pharma, BASF, Evonik, Seppic, Lubrizol, Pfanstiehl, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Parenteral Excipients, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parenteral Excipients.
The Parenteral Excipients market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Parenteral Excipients market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parenteral Excipients manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck
Ashland
Roquette
Croda Pharma
BASF
Evonik
Seppic
Lubrizol
Pfanstiehl
Segment by Type
Solubilizers
Bulker
Preservatives
Solvents
Others
Segment by Application
Precision Medicine
Biopharmaceuticals
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Parenteral Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Parenteral Excipients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Parenteral Excipients Market Overview
1.1 Product Definition
1.2 Parenteral Excipients by Type
1.2.1 Global Parenteral Excipients Market Value Comparison by Type (2024 VS 2031)
1.2.2 Solubilizers
1.2.3 Bulker
1.2.4 Preservatives
1.2.5 Solvents
1.2.6 Others
1.3 Parenteral Excipients by Application
1.3.1 Global Parenteral Excipients Market Value by Application (2024 VS 2031)
1.3.2 Precision Medicine
1.3.3 Biopharmaceuticals
1.3.4 Others
1.4 Global Parenteral Excipients Market Size Estimates and Forecasts
1.4.1 Global Parenteral Excipients Revenue 2020-2031
1.4.2 Global Parenteral Excipients Sales 2020-2031
1.4.3 Global Parenteral Excipients Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Parenteral Excipients Market Competition by Manufacturers
2.1 Global Parenteral Excipients Sales Market Share by Manufacturers (2020-2025)
2.2 Global Parenteral Excipients Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Parenteral Excipients Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Parenteral Excipients, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Parenteral Excipients, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Parenteral Excipients, Product Type & Application
2.7 Global Key Manufacturers of Parenteral Excipients, Date of Enter into This Industry
2.8 Global Parenteral Excipients Market Competitive Situation and Trends
2.8.1 Global Parenteral Excipients Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Parenteral Excipients Players Market Share by Revenue
2.8.3 Global Parenteral Excipients Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Parenteral Excipients Market Scenario by Region
3.1 Global Parenteral Excipients Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Parenteral Excipients Sales by Region: 2020-2031
3.2.1 Global Parenteral Excipients Sales by Region: 2020-2025
3.2.2 Global Parenteral Excipients Sales by Region: 2026-2031
3.3 Global Parenteral Excipients Revenue by Region: 2020-2031
3.3.1 Global Parenteral Excipients Revenue by Region: 2020-2025
3.3.2 Global Parenteral Excipients Revenue by Region: 2026-2031
3.4 North America Parenteral Excipients Market Facts & Figures by Country
3.4.1 North America Parenteral Excipients Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Parenteral Excipients Sales by Country (2020-2031)
3.4.3 North America Parenteral Excipients Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Parenteral Excipients Market Facts & Figures by Country
3.5.1 Europe Parenteral Excipients Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Parenteral Excipients Sales by Country (2020-2031)
3.5.3 Europe Parenteral Excipients Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Parenteral Excipients Market Facts & Figures by Region
3.6.1 Asia Pacific Parenteral Excipients Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Parenteral Excipients Sales by Region (2020-2031)
3.6.3 Asia Pacific Parenteral Excipients Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Parenteral Excipients Market Facts & Figures by Country
3.7.1 Latin America Parenteral Excipients Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Parenteral Excipients Sales by Country (2020-2031)
3.7.3 Latin America Parenteral Excipients Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Parenteral Excipients Market Facts & Figures by Country
3.8.1 Middle East and Africa Parenteral Excipients Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Parenteral Excipients Sales by Country (2020-2031)
3.8.3 Middle East and Africa Parenteral Excipients Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Parenteral Excipients Sales by Type (2020-2031)
4.1.1 Global Parenteral Excipients Sales by Type (2020-2025)
4.1.2 Global Parenteral Excipients Sales by Type (2026-2031)
4.1.3 Global Parenteral Excipients Sales Market Share by Type (2020-2031)
4.2 Global Parenteral Excipients Revenue by Type (2020-2031)
4.2.1 Global Parenteral Excipients Revenue by Type (2020-2025)
4.2.2 Global Parenteral Excipients Revenue by Type (2026-2031)
4.2.3 Global Parenteral Excipients Revenue Market Share by Type (2020-2031)
4.3 Global Parenteral Excipients Price by Type (2020-2031)
5 Segment by Application
5.1 Global Parenteral Excipients Sales by Application (2020-2031)
5.1.1 Global Parenteral Excipients Sales by Application (2020-2025)
5.1.2 Global Parenteral Excipients Sales by Application (2026-2031)
5.1.3 Global Parenteral Excipients Sales Market Share by Application (2020-2031)
5.2 Global Parenteral Excipients Revenue by Application (2020-2031)
5.2.1 Global Parenteral Excipients Revenue by Application (2020-2025)
5.2.2 Global Parenteral Excipients Revenue by Application (2026-2031)
5.2.3 Global Parenteral Excipients Revenue Market Share by Application (2020-2031)
5.3 Global Parenteral Excipients Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Parenteral Excipients Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Parenteral Excipients Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Ashland
6.2.1 Ashland Company Information
6.2.2 Ashland Description and Business Overview
6.2.3 Ashland Parenteral Excipients Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ashland Parenteral Excipients Product Portfolio
6.2.5 Ashland Recent Developments/Updates
6.3 Roquette
6.3.1 Roquette Company Information
6.3.2 Roquette Description and Business Overview
6.3.3 Roquette Parenteral Excipients Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roquette Parenteral Excipients Product Portfolio
6.3.5 Roquette Recent Developments/Updates
6.4 Croda Pharma
6.4.1 Croda Pharma Company Information
6.4.2 Croda Pharma Description and Business Overview
6.4.3 Croda Pharma Parenteral Excipients Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Croda Pharma Parenteral Excipients Product Portfolio
6.4.5 Croda Pharma Recent Developments/Updates
6.5 BASF
6.5.1 BASF Company Information
6.5.2 BASF Description and Business Overview
6.5.3 BASF Parenteral Excipients Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BASF Parenteral Excipients Product Portfolio
6.5.5 BASF Recent Developments/Updates
6.6 Evonik
6.6.1 Evonik Company Information
6.6.2 Evonik Description and Business Overview
6.6.3 Evonik Parenteral Excipients Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Evonik Parenteral Excipients Product Portfolio
6.6.5 Evonik Recent Developments/Updates
6.7 Seppic
6.7.1 Seppic Company Information
6.7.2 Seppic Description and Business Overview
6.7.3 Seppic Parenteral Excipients Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Seppic Parenteral Excipients Product Portfolio
6.7.5 Seppic Recent Developments/Updates
6.8 Lubrizol
6.8.1 Lubrizol Company Information
6.8.2 Lubrizol Description and Business Overview
6.8.3 Lubrizol Parenteral Excipients Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Lubrizol Parenteral Excipients Product Portfolio
6.8.5 Lubrizol Recent Developments/Updates
6.9 Pfanstiehl
6.9.1 Pfanstiehl Company Information
6.9.2 Pfanstiehl Description and Business Overview
6.9.3 Pfanstiehl Parenteral Excipients Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pfanstiehl Parenteral Excipients Product Portfolio
6.9.5 Pfanstiehl Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Parenteral Excipients Industry Chain Analysis
7.2 Parenteral Excipients Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Parenteral Excipients Production Mode & Process Analysis
7.4 Parenteral Excipients Sales and Marketing
7.4.1 Parenteral Excipients Sales Channels
7.4.2 Parenteral Excipients Distributors
7.5 Parenteral Excipients Customer Analysis
8 Parenteral Excipients Market Dynamics
8.1 Parenteral Excipients Industry Trends
8.2 Parenteral Excipients Market Drivers
8.3 Parenteral Excipients Market Challenges
8.4 Parenteral Excipients Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Parenteral Excipients Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Parenteral Excipients Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Parenteral Excipients Market Competitive Situation by Manufacturers in 2024
Table 4. Global Parenteral Excipients Sales (Tons) of Key Manufacturers (2020-2025)
Table 5. Global Parenteral Excipients Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Parenteral Excipients Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Parenteral Excipients Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Parenteral Excipients Average Price (US$/Ton) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Parenteral Excipients, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Parenteral Excipients, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Parenteral Excipients, Product Type & Application
Table 12. Global Key Manufacturers of Parenteral Excipients, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Parenteral Excipients by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parenteral Excipients as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Parenteral Excipients Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Parenteral Excipients Sales by Region (2020-2025) & (Tons)
Table 18. Global Parenteral Excipients Sales Market Share by Region (2020-2025)
Table 19. Global Parenteral Excipients Sales by Region (2026-2031) & (Tons)
Table 20. Global Parenteral Excipients Sales Market Share by Region (2026-2031)
Table 21. Global Parenteral Excipients Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Parenteral Excipients Revenue Market Share by Region (2020-2025)
Table 23. Global Parenteral Excipients Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Parenteral Excipients Revenue Market Share by Region (2026-2031)
Table 25. North America Parenteral Excipients Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Parenteral Excipients Sales by Country (2020-2025) & (Tons)
Table 27. North America Parenteral Excipients Sales by Country (2026-2031) & (Tons)
Table 28. North America Parenteral Excipients Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Parenteral Excipients Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Parenteral Excipients Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Parenteral Excipients Sales by Country (2020-2025) & (Tons)
Table 32. Europe Parenteral Excipients Sales by Country (2026-2031) & (Tons)
Table 33. Europe Parenteral Excipients Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Parenteral Excipients Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Parenteral Excipients Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Parenteral Excipients Sales by Region (2020-2025) & (Tons)
Table 37. Asia Pacific Parenteral Excipients Sales by Region (2026-2031) & (Tons)
Table 38. Asia Pacific Parenteral Excipients Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Parenteral Excipients Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Parenteral Excipients Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Parenteral Excipients Sales by Country (2020-2025) & (Tons)
Table 42. Latin America Parenteral Excipients Sales by Country (2026-2031) & (Tons)
Table 43. Latin America Parenteral Excipients Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Parenteral Excipients Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Parenteral Excipients Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Parenteral Excipients Sales by Country (2020-2025) & (Tons)
Table 47. Middle East and Africa Parenteral Excipients Sales by Country (2026-2031) & (Tons)
Table 48. Middle East and Africa Parenteral Excipients Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Parenteral Excipients Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Parenteral Excipients Sales (Tons) by Type (2020-2025)
Table 51. Global Parenteral Excipients Sales (Tons) by Type (2026-2031)
Table 52. Global Parenteral Excipients Sales Market Share by Type (2020-2025)
Table 53. Global Parenteral Excipients Sales Market Share by Type (2026-2031)
Table 54. Global Parenteral Excipients Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Parenteral Excipients Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Parenteral Excipients Revenue Market Share by Type (2020-2025)
Table 57. Global Parenteral Excipients Revenue Market Share by Type (2026-2031)
Table 58. Global Parenteral Excipients Price (US$/Ton) by Type (2020-2025)
Table 59. Global Parenteral Excipients Price (US$/Ton) by Type (2026-2031)
Table 60. Global Parenteral Excipients Sales (Tons) by Application (2020-2025)
Table 61. Global Parenteral Excipients Sales (Tons) by Application (2026-2031)
Table 62. Global Parenteral Excipients Sales Market Share by Application (2020-2025)
Table 63. Global Parenteral Excipients Sales Market Share by Application (2026-2031)
Table 64. Global Parenteral Excipients Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Parenteral Excipients Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Parenteral Excipients Revenue Market Share by Application (2020-2025)
Table 67. Global Parenteral Excipients Revenue Market Share by Application (2026-2031)
Table 68. Global Parenteral Excipients Price (US$/Ton) by Application (2020-2025)
Table 69. Global Parenteral Excipients Price (US$/Ton) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Parenteral Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. Merck Parenteral Excipients Product
Table 74. Merck Recent Developments/Updates
Table 75. Ashland Company Information
Table 76. Ashland Description and Business Overview
Table 77. Ashland Parenteral Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. Ashland Parenteral Excipients Product
Table 79. Ashland Recent Developments/Updates
Table 80. Roquette Company Information
Table 81. Roquette Description and Business Overview
Table 82. Roquette Parenteral Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. Roquette Parenteral Excipients Product
Table 84. Roquette Recent Developments/Updates
Table 85. Croda Pharma Company Information
Table 86. Croda Pharma Description and Business Overview
Table 87. Croda Pharma Parenteral Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. Croda Pharma Parenteral Excipients Product
Table 89. Croda Pharma Recent Developments/Updates
Table 90. BASF Company Information
Table 91. BASF Description and Business Overview
Table 92. BASF Parenteral Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. BASF Parenteral Excipients Product
Table 94. BASF Recent Developments/Updates
Table 95. Evonik Company Information
Table 96. Evonik Description and Business Overview
Table 97. Evonik Parenteral Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. Evonik Parenteral Excipients Product
Table 99. Evonik Recent Developments/Updates
Table 100. Seppic Company Information
Table 101. Seppic Description and Business Overview
Table 102. Seppic Parenteral Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 103. Seppic Parenteral Excipients Product
Table 104. Seppic Recent Developments/Updates
Table 105. Lubrizol Company Information
Table 106. Lubrizol Description and Business Overview
Table 107. Lubrizol Parenteral Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 108. Lubrizol Parenteral Excipients Product
Table 109. Lubrizol Recent Developments/Updates
Table 110. Pfanstiehl Company Information
Table 111. Pfanstiehl Description and Business Overview
Table 112. Pfanstiehl Parenteral Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 113. Pfanstiehl Parenteral Excipients Product
Table 114. Pfanstiehl Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Parenteral Excipients Distributors List
Table 118. Parenteral Excipients Customers List
Table 119. Parenteral Excipients Market Trends
Table 120. Parenteral Excipients Market Drivers
Table 121. Parenteral Excipients Market Challenges
Table 122. Parenteral Excipients Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Parenteral Excipients
Figure 2. Global Parenteral Excipients Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Parenteral Excipients Market Share by Type: 2024 & 2031
Figure 4. Solubilizers Product Picture
Figure 5. Bulker Product Picture
Figure 6. Preservatives Product Picture
Figure 7. Solvents Product Picture
Figure 8. Others Product Picture
Figure 9. Global Parenteral Excipients Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Parenteral Excipients Market Share by Application: 2024 & 2031
Figure 11. Precision Medicine
Figure 12. Biopharmaceuticals
Figure 13. Others
Figure 14. Global Parenteral Excipients Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Parenteral Excipients Market Size (2020-2031) & (US$ Million)
Figure 16. Global Parenteral Excipients Sales (2020-2031) & (Tons)
Figure 17. Global Parenteral Excipients Average Price (US$/Ton) & (2020-2031)
Figure 18. Parenteral Excipients Report Years Considered
Figure 19. Parenteral Excipients Sales Share by Manufacturers in 2024
Figure 20. Global Parenteral Excipients Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Parenteral Excipients Players: Market Share by Revenue in Parenteral Excipients in 2024
Figure 22. Parenteral Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Parenteral Excipients Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Parenteral Excipients Sales Market Share by Country (2020-2031)
Figure 25. North America Parenteral Excipients Revenue Market Share by Country (2020-2031)
Figure 26. United States Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Parenteral Excipients Sales Market Share by Country (2020-2031)
Figure 29. Europe Parenteral Excipients Revenue Market Share by Country (2020-2031)
Figure 30. Germany Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Parenteral Excipients Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Parenteral Excipients Revenue Market Share by Region (2020-2031)
Figure 37. China Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Parenteral Excipients Sales Market Share by Country (2020-2031)
Figure 45. Latin America Parenteral Excipients Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Colombia Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Parenteral Excipients Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Parenteral Excipients Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Parenteral Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Parenteral Excipients by Type (2020-2031)
Figure 56. Global Revenue Market Share of Parenteral Excipients by Type (2020-2031)
Figure 57. Global Parenteral Excipients Price (US$/Ton) by Type (2020-2031)
Figure 58. Global Sales Market Share of Parenteral Excipients by Application (2020-2031)
Figure 59. Global Revenue Market Share of Parenteral Excipients by Application (2020-2031)
Figure 60. Global Parenteral Excipients Price (US$/Ton) by Application (2020-2031)
Figure 61. Parenteral Excipients Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
